Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model

Tuberculosis

Volumn 87, Issue 2, 2007, Pages 134-144

  Rubakova, Elvira ^a   Petrovskaya, Svetlana ^a   Pichugin, Alexander ^a   Khlebnikov, Valentine ^b   McMurray, David ^c   Kondratieva, Elena ^a   Baturina, Irina ^a   Kondratieva, Tatiana ^a   Apt, Alexander ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

^b Institute of Engineering Immunology   (Russian Federation)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

DC vaccines; Immune response specificity; Murine TB; Protection

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MYCOBACTERIUM ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; BONE MARROW; C57BL 6 MOUSE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SPECIFICITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FETAL CALF SERUM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD11C; BONE MARROW CELLS; CATTLE; CELL DIVISION; CELLS, CULTURED; COLONY COUNT, MICROBIAL; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITOPES; FETAL BLOOD; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; SPLEEN; T-LYMPHOCYTES; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 33846782721     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2006.06.002     Document Type: Article

References (42)

1. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J Am Med Assoc 271 (1994) 698-702
2. Rodrigues L.C., Divan V.D., and Wheeler J.G. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis. Int J Epidemiol 22 (1993) 1154-1158
3. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 (1995) 1339-1345
4. Feng C.G., Palendira U., Demangel C., Spratt J.M., Malin A.S., and Britton W.J. Priming with DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Gurin against tuberculosis. Infect Immun 69 (2001) 4174-4176
5. Ferraz J.C., Stavropulos E., Yang M., Coade S., Espitia C., Lowrie D.B., et al. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65 and Apa antigens improves protection against tuberculosis. Infect Immun 72 (2004) 6945-6950
6. Conradt P., Hess J., and Kaufmann S.H.E. Cytolytic T cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin. Microbes Infect 1 (1999) 753-764
7. Horwitz M.A., Harth G., Dillon B.J., and Maslesa-Galic' S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97 (2000) 13853-13858
8. Grode L., Seiler P., Baumann S., Hess J., Brinkmann V., Nasser Eddine A., et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115 (2005) 2472-2479
9. Elhay M.J., and Andersen P. Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol 75 (1997) 595-603
10. Reynes J., Perez C., Lamaury I., Janbon F., and Bertrand A. Bacille Calmette-Guerin adenitis 30 years after immunization in a patient with AIDS. J Inf Dis 160 (1989) 727-731
11. Doherty T.M., Olsen A.W., Weischenfeldt J., Huygen K., D'Souza S., Kondratieva T.K., et al. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190 (2004) 2146-2153
12. Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis 85 (2005) 29-38
13. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45 (1997) 115-131
14. Inaba K., Metlay J.P., Crowley M.T., and Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172 (1990) 631-640
15. Inaba K., Inaba M., Naito M., and Steinman R.M. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178 (1993) 479-488
16. Steinman R.M. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9 (1991) 271-296
17. Demangel C., Bean A.G.D., Martin E., Feng C.G., Kamath A.T., and Britton W.J. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis BCG-infected dendritic cells. Eur J Immunol 29 (1999) 1972-1979
18. Demangel C., and Britton W.J. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol 78 (2000) 318-324
19. Henderson R.A., Watkins S.C., and Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 159 (1997) 635-643
20. Flynn J.L., and Chan J. Immunology of tuberculosis. Ann Rev Immunol 19 (2001) 93-129
21. North R., and Jung Y- J. Immunity to tuberculosis. Ann Rev Immunol 22 (2004) 599-623
22. Banchereau J., and Steinman T.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
23. Cella M., Sallusto F., and Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9 (1997) 10-16
24. Tascon R.E., Soares C.S., Ragno S., Stavropoulos E., Hirst E.M.A., and Colston M.J. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99 (2000) 473-480
25. Gonzalez-Juarrero M., Turner J., Basaraba R.J., Belisle J.T., and Orme I.M. Florid pulmonary inflammatory responses in mice vaccinated with antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosis. Cell Immunol 220 (2002) 13-19
26. +-T cell epitopes from antigen 85A. Infect Immun 70 (2002) 1623-1626
27. Toldbod HE, et al. Potent influence of bovine serum protein in experimental dendritic cell-based experimental protocols. Scand J Immunol 2003.
28. Inaba K., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., et al. Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulating factor. J Exp Med 176 (1992) 1693-1702
29. Lyadova I.V., Yeremeev V.V., Majorov K.B., Nikonenko B.V., Khaidukov S.V., Kondratieva T.K., et al. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun 66 (1998) 4981-4988
30. Nikonenko B.V., Averbakh Jr. M.M., Lavebratt C., Schurr E., and Apt A.S. Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tubercle Lung Dis 80 (2000) 15-25
31. Apt A.S., Avdienko V.G., Nikonenko B.V., Moroz A.M., and Skamene E. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol 94 (1993) 322-329
32. Lutz M.B., Kukutsch N., Ogilvie A.L.G., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Meth 223 (1999) 77-92
33. Van Gisbergen K.P.J.M., Geijtenbeek T.B.H., and Van Kooyk Y. Close encounters of neutrophils and DCs. Trends Immunol 26 (2005) 626-631
34. Bennouna S., Bliss S.K., Curiel T.J., and Denkers E.Y. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 171 (2003) 6052-6058
35. Kleindienst P., and Brocker T. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170 (2003) 2817-2823
36. Bennouna S., and Denkers E.Y. Microbial antigen triggers rapid mobilization to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-α production. J Immunol 174 (2005) 4845-4851
37. Eruslanov E.B., Lyadova I.V., Kondratieva T.K., Majorov K.B., Scheglov I.V., Orlova M.O., et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73 (2005) 1744-1753
38. Harshyne L.A., Watkins S.C., Gambotto A., and Barratt-Boyes S.M. Dendritic cells acquire antigens from live cells for cross presentation to CTL. J Immunol 166 (2001) 3717-3723
39. Mansour Haeryfar S.M. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation. Trends Immunol 26 (2005) 311-317
40. Finkelman F.D., Lees A., Bimbaum R., Gause W.C., and Morris S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 157 (1996) 1406-1414
41. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194 (2001) 769-779
42. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L.J., Kukutsch N., Rossner S., et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30 (2000) 1813-1822